Upload
massimiliano-landini
View
215
Download
0
Embed Size (px)
Citation preview
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
1/16
SOME STATISTICAL TECHNIQUES FOR BIO-EFFICACY TRIALS
Rajender Parsad
I.A.S.R.I., Library Avenue, New Delhi - 110 012
Biological assays and probit analysis are quite useful in designing of bio-efficacy trialsand analysis of experimental data. A biological assay (bioassay) is a set of techniques
relevant to the comparisons between the biological strength of alternative but similar
biological stimuli (for example, a vitamin, a drug, a mental test, a physical force, aninsecticide, plant extract, etc.) based on the responses produced by them on the subjects,
such as subhuman primates' (or human) living tissues, plants or isolated organs, insects,
etc. Normally two preparations of the stimulus, one of known strength (standardpreparation) and another of unknown strength (test preparation), both with quantitativedoses are applied to a set of living organisms. The general objective of bioassays is to
draw statistically valid conclusions on the relative potency of the test preparation with
respect to the standard one. Usually when a drug or a stimulus is applied to a subject itinduces a change in some measurable characteristic that is designated as the response
variable. In this setup, the dose may have several chemically or therapeutically different
ingredients, while the response may also be multivariable. Thus the stimulus-response ordose-response relationships for the two preparations, both subject to inherent stochastic
variability, are to be compared in a sound statistical manner so as to cast light on their
relative performance with respect to the set objectives.
Let ds and dtdenote the doses of the standard and the test preparations respectively such
that each of them produces a pre-assigned response in some living organism. Then the
ratio ts dd= is called the relative potency of the test preparation. If is greater than
unity, it shows that a smaller dose of the test preparation produces as much response as arelatively larger dose of the standard preparation and hence the potency of the test
preparation is greater than that of the standard preparation. Similarly when is less thanunity the potency of the test preparation is smaller than that of the standard preparation.
Naturally, such statistical procedures may depend on the nature of the stimulus andresponse, as well as on other extraneous experimental (biological or therapeutic)
considerations. As may be the case with some competing chemicals for removing the
effect of common insects, the two (i.e. test and standard) preparations may not have thesame chemical or pharmacological constitution, and hence, statistical modeling may need
a somewhat different approach than in common laboratory experimentation.
Nevertheless, in many situations the test preparation may behave (in terms of theresponse/tolerance distribution) as if it is a dilution or concentration of the standard one.For this reason, often such bioassays are designated to compare the relative performance
of two drugs under the dilution-concentration postulation (i.e., assays with two
preparations containing the same effective ingredients which is responsible for theresponse), and are thereby termed dilution assays or analytical dilution assays. Dilution
assays are classified into two broad categories: direct dilution and indirect dilution. In a
direct assay, for each preparation the exact amount of dose needed to produce a specified
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
2/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-62
response is directly measured, so that the response is certain while the dose is a non-negative random variable that defines the tolerance distribution. Statistical modeling of
these tolerance distributions enables us to define the relative potency in a statistically
interpretable and analyzable manner, often in terms of the parameters associated with thetolerance distributions. However, a direct assay is practicable only when both the
preparations are capable of administration in such a way that the minimal amountsneeded to produce the specified response can directly be measured. In most assays,however, the response is not directly measurable and indirect methods are used to
estimate the dose corresponding to a given response via a dose response relationship,
such assays are known as indirect assays. In an indirect assay the dose is generally
administered at some prefixed (usually non-stochastic) levels, and at each level theresponse is observed for subjects included in the study. Thus, the dose is generally non-
stochastic and the stochastic response at each level provides information about the
tolerance distribution for the particular preparation. If the response is a quantitativevariable (magnitude of some property like survival time, weight, etc.), then we have an
indirect quantitative assay, while if the response is quantal in nature (i.e. all or nothing),
then we have a quantal assay. Both of these assays are commonly adopted in statisticalpractice. Within this framework, the nature of the dose-response regression may call for
suitable transformations on the dose variable (called the dosage or dosemetameter)
and/or the response variable, called the response-metameter. The basic objective of such
transformations is to achieve a linear dose-response regression that may inducesimplifications in statistical modeling and analysis schemes. Ifz represents the dose in
the original scale, then the two transformations that have been found useful in bioassay
work are (i) )z(logx e= and (ii)zx = , where 0> is a known constant. The first of
these gives rise toparallel line assays and assays based on the second transformation are
called as slope ratio assays. These assays normally fall under the category of
quantitative indirect assays. In these assays, the transformation of response variable is
generally not needed. In quantal assays, however, the response variable is generallysubjected to theprobit(or normit) and logittransformations, based on normal and logistic
distributions, respectively.
In a parallel line assay, the two dose-response regression lines (one for the standard
preparation and another for the test preparation) are taken as parallel and further the
errors in the two regression equations are assumed to have the same distribution (oftentaken as normal). Therefore, after fitting of these two regression lines, it is important to
test for the parallelism for the regression lines before making any conclusions. A
parallel line assay is called as symmetric if the standard and test preparations involve thesame number of doses, otherwise it is called an asymmetric assay. The analysis of the
parallel line assay for conducting the validity tests and for estimating the relative potencybecomes very much simplified when the doses of each of the preparations are taken in
geometric progression.
In slope ratio assays it is assumed that the two regression lines intersect at the same point
on the response axis, i.e., they are assumed to have the same intercept. As the dose takesvalue zero on the response axis, it is necessary to include a blank dose in the assay for the
validity test. Thus if there are k doses for each of the two preparations in a slope ratio
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
3/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-63
assay, the total number of doses is 2k+1. If against each of these doses an equal numberof subjects, say, n is allotted, the assay is 2k+1 symmetrical slope ratio assay, otherwise
asymmetrical slope ratio assays. In slope ratio assays, the blank, the intersection
contrasts and the two regression contrasts are of major importance.
In quantal assays, occurrence or non-occurrence will depend upon the intensity of thestimulus. For any one subject, under controlled conditions there will be a certain level ofintensity below which the response does not occur and above which the response occurs.
Such a value has often been called a thresholdor limen, but the term tolerance is now
widely accepted. This tolerance value will vary from one member to another of the
population used, frequently between quite wide limits. When the characteristic responseis quantitative, the stimulus intensity needed to produce a response of any given
magnitude will show similar variation between individuals. In either case, the value for
an individual also is likely to vary from one occasion to another as a result ofuncontrolled internal or external condition.
In these assays, the earlier attempts were made to characterize the effectiveness of astimulus in relation to a quantal response referred to the minimal effective dose or for a
more restricted class of stimuli, the minimal lethal dose terms which failed to take
account of the variation in tolerance within a population. The logical weakness of such
concepts is the assumption that there is a dose for any given chemical which is only justsufficient to kill all or most of the insects of a given species, and, doses a bit lesser would
not kill any insect of that species. Any worker, however, accustomed to the estimation of
toxicity knows that these assumptions do not represent the truth.
It might be thought that the minimal lethal dose of a poison could instead be defined asthe dose just sufficient to kill a member of the species with the least possible tolerance,
and also a maximal non-lethal dose as the dose which will just fail to kill the most
resistant member. Undoubtedly some doses are so low that no test subject will succumbto them and others so high as to prove fatal at all, but considerable difficulties attend
determination of the end-points of these ranges. Even when the tolerance of an individual
can be measured directly, to say from measurements on a sample of ten or a hundred thatthe lowest tolerance found indicated the minimal lethal dose would be unwise: a larger
sample might contain a more extreme member. When only quantal responses for selected
doses can be recorded the difficulty is increased, and the occurrence of exceptional
individuals in the batches at different dose levels may seriously bias the final estimates.The problem is in fact that of determining the dose at which the dose response curve for
the whole population needs the 0% or 100% levels of kill and even a very large
experiment could scarcely estimate these points with any accuracy.
An escape from the dilemma can be made by giving attention to a different and more
satisfactorily defined characteristics, the median lethal dose, or, as a more general term toinclude response other then death, the median effective dose. This is the dose that will
produce a response in half the population. The median effective dose is commonly
referred to as the ED 50, the more restricted concept of median lethal dose as the LD 50.Analogous symbols were used for doses effective for other proportions of the population,
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
4/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-64
ED90 being the dose that causes 90% to respond. With a fixed total number of subjecteffective doses in the neighborhood of ED50 can usually be estimated more precisely
then those for more extreme percentage levels and this is, therefore, particularly favoured
in expressing the effectiveness of the stimulus. The ED50 alternatively be regarded asthe median of the tolerance distribution that is to say the level of tolerance such that
exactly half the subjects lie on either side of it.
The ED 50 or LD 50 can easily be calculated using the Probit Analysis. For doing this,
we conduct an experiment on different doses of an insecticide applied under standardized
conditions to samples of an insect species and record the number of insects killed and the
number of insects exposed. Now the ratio of the number insects died (the subjectsresponded) to that of the number of insects exposed (subjects exposed) gives the
probability or proportion (P) of the insects killed at a particular dose. Now this
probability data is subjected to probit or logit transformation.
Probit transformation is nothing but the 5 more than the normal equivalent deviate. In
this transformation, we replace each of the observed proportions with the value ofstandard normal curve below which the observed proportion of the area is found. To
avoid negative numbers, the constant 5 is usually added. For example, if half (0.5) of the
subjects respond at a particular dose, the corresponding probit value is 0, since half of the
area in a standard normal falls below a Z score of 0. When the constant 5 is added, thetransformed value for the proportion is 5. If the observed proportion is 0.95, the
corresponding probit value is 1.64. Addition of the constant value of 5 makes this 6.64.
Likewise, if 10% of the subjects respond, then the normal equivalent deviate is -1.29 andhence the probit value is 3.7.
In the logit transformation, the observed proportion P is changed to
( )( ) 52
1ln+
PP
The quantity ( )( )PP 1ln is called a logit. Division by 2 and addition of the constant 5 isdone to keep the values positive and to keep the two types of transformations on a similar
scale. If the observed proportion is 0.5, the logit-transformed value is 0+5, the same as
the probit-transformed value. Similarly, if the observed proportion is 0.95, the logit-transformed value is 6.47 (1.47+5). This differs somewhat from the corresponding probit
value of 6.64. (In most situations, analyses based on logits and probits give very similar
results.)
The above is discussion about the transformation of the observed proportions. The dose
are transformed to the logarithmic scale. When the experimental data on the relation
between dose and proportion of the subjects responded have been obtained, either agraphical or a statistical approach in terms of fitting of response metameter-dose
metameter linear regression relationship can be used to estimate the parameters.
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
5/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-65
The graphical approach is rapid and sufficiently good for many purposes. In thisapproach, the probits are plotted against the dose-metameter, and a straight line is drawn
by eye to fit the points as satisfactorily as possible. The line must be so drawn that the
differences between the observed probit values and the probit values obtained by the lineat each value of dose metameter are as small as possible. The value of log ED 50 is
estimated from this line asx at which probit value is 5. In the second approach, we fit asimple linear regression equation
Probit ( iii ebxaP ++=) ,
where iP is the observed proportion corresponding at close ix (usually the log of the dose
is used instead of the actual dose), a and b are respectively the intercept and slope of the
regression equation and ie is the random error. From the fitted regression equation, the
log ED 50 (x) is obtained as that value for which probit value is 5.
The goodness of fit of the model, the Pearsons chi-square goodness of fit test. For this
we obtain the expected frequencies are obtained. The expected frequencies are the
number of subjects responded and is obtained by obtaining the estimated Probit ( iP ) from
the fitted model. Subtract 5 from he model. Now obtain the area under the normal curve
below this point. This gives the percentage of the subjects responded. Now using thenumber of subjects tried, one can obtain the expected number of subjects responded
( ii Pn ) for the dose i. If ir is the corresponding observed number of the subjects affected,
then we obtain, residuals as iii Pnr . Now the Pearson goodness of fit chi-square is
obtained as)1(
)( 2
iii
iii
PPn
Pnr
. The degrees of freedom are equal to the number of doses
minus he number of estimated parameters. To be clearer, consider the following examplefrom Finney (1971).
Example 1: Finney (1971) gave a data representing the effect of a series of doses of
carotene (an insecticide) when sprayed on Macrosiphoniella sanborni (some obscure
insects). The Table below contains the concentration, the number of insects tested ateach dose, the proportion dying and the probit transformation (probit+5) of each of the
observed proportions.
Concentration
(mg/1)
No. of
insects (n)
No. of
affected (r)
%kill (P) Log
concentration
(x)
Empirical
probit
10.2 50 44 88 1.01 6.18
7.7 49 42 86 0.89 6.08
5.1 46 24 52 0.71 5.053.8 48 16 33 0.58 4.56
2.6 50 6 12 0.41 3.82
0 49 0 0 - -
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
6/16
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
7/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-67
The above discussion relates to only one stimulus. If there is more than one stimulusvariables terms are added to the model for each of the stimuli. We get the regression
coefficients and standard errors, intercept and standard error, Pearson goodness-of-fit chi-
square, observed and expected frequencies, and confidence intervals for effective levelsof independent variable(s). If the Pearson goodness-of-fit chi-square is non-significant,
we calculate the value of the dose-metameter for which the value of the responsemetameter (probit) is 5. The antilogarthmic of this dose metameter is the ED 50 or LD50.
The ED 50 alone does not fully describe the effectiveness of the stimulus. Two
insecticides/fungicides may require the same rate of application in order to be lethal tohalf of the population, but, if the distribution of tolerances has a lesser 'spread' for one
than for the other, any increase or decrease from this rate will produce a greater change in
mortality for the first than for the second. Therefore, it is necessary to give the standarderrors and fiducial limits associated with ED 50 or LD 50. Besides knowing the ED 50 of
a particular chemical preparation, the experimenter may be interested in comparing the
relative potencies of the several chemical preparations. One is required to fit the probitregression lines for each of the chemical preparations separately. These regression lines
are required to be tested for parallelism. If the probit regression lines are parallel for the
different chemical preparations, then the relative potency is constant at all levels of theresponse.
The choice of an efficient experimental design is based on the nature of the variability in
the experimental material, environmental conditions and objectives for conducting abioassay. The design may be a randomized complete block design, an incomplete block
design, design for factorial experiments etc.
Computation of corrected efficacy %
The discussion earlier assumed that the responses of the test subjects is due to the appliedstimuli alone. In some experiments, however, the responses can occur at zero dose; either
control batches of the subjects have received zero dose or a sequence of low doses
indicating a minimal response rate greater than zero. In a pesticide trials some insectsmay die from natural causes. In such situations, it is required to work with crrected
mortality or corrected proportions of the responses. Corrected efficacy % in pesticide
trials can be computed by using the Abbott, Henderson and Tilton, Schneider-Orelli orSun-Shepard formulas. The selection of appropriate formula is depending on two factors
viz.
1. Trial condition (infestation or population stability and homogeneity).2. The data on your hand (live individuals or mortality %).
The following table is of help in choosing the right formula
Available data Uniform population Non-uniform population
Infestation or live
individualsAbbott Henderson-Tilton
Mortality or dead
individualsSchneider-Orelli Sun-Shepard
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
8/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-68
These formulae are given in the sequel.
Abbott's formula
100*1
=
treatmentafterCoinn
treatmentafterTinn%Corrected
where : n = Insect population, T = treated, Co =control
Henderson Tilton's formula
100*treatmentbeforeTinn*treatmentafterCoinn
treatmentafterTinn*treatmentbeforeCoinn1%Corrected
=
where : n = Insect population, T= treated, Co =control
The above two formulae can be combined into one and written as
Corrected % = 100
x
yx
where x = % survivorship in the control group (concentration of pesticide=0)
y = % survivorship in the experimental group.
Schneider-Orelli's formula
100*controlin%Mortality-100
controlin%Mortality-in treatedMortality%%Corrected
=
Sun-Shepard's formula
100*controlin%Change100
controlin%changein treatedMortality%%Corrected
+
+=
If the response is other than the death, then we may replace mortality by responded andsurvivorship by non-responded. Once the corrected responded % is obtained, then same
procedure as above may be adoted.
{This note is prepared from the book Probit Analysis by D. J. Finney (1971)}.
Steps for carrying out the Probit Analysis using MINITAB
For the data given in example 1, first enter the data in the Worksheet of MINITAB inthree coumns C1: dose; C2: total Insects; C3: Insects killed or affected. Now create a
column C4 for logdose by using LOGT(C1) using menu Calc.
Now Choose Stat > Reliability/Survival > Probit Analysis.
From the dialog box; Choose the data format "Success/trial" or "Response/frequency". In
the present case, the data is in success trial format, therefore, enter C3, the column
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
9/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-69
containing the number of successes in Number of Successes box and C2, the total numberof trials in Number of Trials subbox. In the subbox for stress/stimulus enter C4, the
column containing the logdose. Since, there is only one stimulus, therefore, the subbox
pertaining to Factor (optional) may be left blank. Choose the distribution as normal.
The other options available on the dialog box are: Estimate, Graphs, Options, Results and
Storage.
Using the option Estimate, One can
- estimate percentiles for the percents you specify. These percentiles are added to thedefault table of percentiles.
- estimate survival probabilities for the stress values you specify.
One can also change the method of estimation for the confidence intervals and the levelof confidence. The default option is two sided 95% fiducial intervals.
Other options may also be used, as and when required. For this example, we chose the
additional percentiles as 65 and survival probabilities for stress level 0.9 (logdose).
Probit Analysis: affect, total versus logdoseDistribution: Normal
Response Information
Variable Value Count
affect Success 132
Failure 111
total Total 243
Estimation Method: Maximum Likelihood
Regression Table
Standard
Variable Coef Error Z P
Constant -2.88746 0.350134 -8.25 0.000
logdose 4.21320 0.478303 8.81 0.000
Log-Likelihood = -120.052
Goodness-of-Fit Tests
Method Chi-Square DF P
Pearson 1.72888 3 0.631
Deviance 1.73897 3 0.628
Tolerance Distribution: Parameter Estimates
Standard 95.0% Normal CI
Parameter Estimate Error Lower Upper
Mean 0.685338 0.0220962 0.642030 0.728646
StDev 0.237349 0.0269451 0.190001 0.296497
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
10/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-70
Table of Percentiles
Standard 95.0% Normal CI
Percent Percentile Error Lower Upper
1 0.133180 0.0686394 -0.0013503 0.267711
2 0.197882 0.0617254 0.0769020 0.318861
3 0.238933 0.0573944 0.126442 0.351423
4 0.269813 0.0541723 0.163638 0.375989
5 0.294933 0.0515787 0.193840 0.396025
6 0.316313 0.0493935 0.219504 0.413123
7 0.335060 0.0474969 0.241967 0.428152
8 0.351845 0.0458160 0.262047 0.441643
9 0.367110 0.0443030 0.280278 0.453943
10 0.381162 0.0429251 0.297031 0.465294
20 0.485580 0.0332991 0.420314 0.550845
30 0.560872 0.0274617 0.507048 0.614696
40 0.625206 0.0238086 0.578542 0.671870
50 0.685338 0.0220962 0.642030 0.728646
60 0.745470 0.0224241 0.701519 0.789420
65 0.776793 0.0233958 0.730939 0.822648
70 0.809804 0.0249330 0.760936 0.858672
80 0.885096 0.0299366 0.826422 0.943771
90 0.989513 0.0389715 0.913131 1.06590
91 1.00357 0.0402991 0.924581 1.08255
92 1.01883 0.0417626 0.936978 1.10068
93 1.03562 0.0433947 0.950564 1.12067
94 1.05436 0.0452427 0.965688 1.14304
95 1.07574 0.0473792 0.982882 1.16860
96 1.10086 0.0499232 1.00301 1.1987197 1.13174 0.0530936 1.02768 1.23580
98 1.17279 0.0573685 1.06035 1.28523
99 1.23750 0.0642153 1.11164 1.36336
Table of Survival Probabilities
95.0% Normal CI
Stress Probability Lower Upper
0.9 0.182888 0.122757 0.258650
Interpretation: The goodness-of-fit tests (p-values = 0.631, 0.628) suggest that the
distribution and the model fits the data adequately. In this case, the fitting is done onnormal equivalent deviate only without adding 5. Therefore, log LD50 or lof ED50
corresponds to the value of Probit=0.Log LD50 is obtained as 0.685338. Therefore, the
stress level at which the 50% of the insects will be killed is (100.685338=4.845 mg/l).
Similarly the stress level at which 65% of the insects will be killed is (100.776793
= 5.981mg/l). At logdose = 0.9, what percentage of insects will be killed? Results indicate that
18.29% of the insects will be killed.
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
11/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-71
Example 2: {Finney (1971): Ex.13} reported an experiment conducted to compare therelative potencies of the three analgesic amidone, phenadoxone and pethidine with
morphine. The technique was to record how many standard electric shocks could be
applied to the tail of a mouse before the mouse squeaked; if the number of shocksincreased by 4 or more after application of the drug, then we say that the mouse has
responded. The data generated alongwith the log dose concentration is given thefollowing table.
Factor Log dose Total Mouse Observed Mouse Responded
(f) (x) (n) (r)
1 0.18 103 191 0.48 120 53
1 0.78 123 83
2 0.18 60 142 0.48 110 54
2 0.78 100 81
3 -0.12 90 313 0.18 80 543 0.48 90 80
4 0.70 60 13
4 0.88 85 274 1.00 60 32
4 1.18 90 55
4 1.30 60 44
1: morphine; 2:amidone; 3: phenadoxone; 4: pethidine.
For the analysis of data follow the same steps as in Example 1 with the addition that in
the factor subbox define factor as f. The results obtained are given in the sequel.
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
12/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-72
Probit Analysis: r, n versus x, f
Distribution: Normal
Response Information
Variable Value Count
r Success 640
Failure 591
n Total 1231
Factor Information
Factor Levels Values
f 4 1, 2, 3, 4
Estimation Method: Maximum Likelihood
Regression Table
Standard
Variable Coef Error Z P
Constant -1.38969 0.114661 -12.12 0.000
x 2.47552 0.173176 14.29 0.000
f
2 0.237877 0.108353 2.20 0.028
3 1.35900 0.129801 10.47 0.000
4 -1.18220 0.132956 -8.89 0.000
Test for equal slopes: Chi-Square = 1.54180 DF = 3 P-
Value = 0.673
Log-Likelihood = -729.327
Multiple degree of freedom test
Term Chi-Square DF P
f 185.015 3 0.000
Goodness-of-Fit Tests
Method Chi-Square DF P
Pearson 4.03105 9 0.909
Deviance 4.03534 9 0.909
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
13/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-73
f = 1: Tolerance Distribution
Parameter Estimates
Standard 95.0% Normal CI
Parameter Estimate Error Lower Upper
Mean 0.561374 0.0291474 0.504247 0.618502
StDev 0.403956 0.0282589 0.352198 0.463319
Table of Percentiles
Standard 95.0% Fiducial CI
Percent Percentile Error Lower Upper
1 -0.378367 0.0689837 -0.533080 -0.257945
2 -0.268249 0.0620774 -0.407031 -0.159538
3 -0.198383 0.0578001 -0.327263 -0.0968963
4 -0.145825 0.0546499 -0.267390 -0.0496399
5 -0.103073 0.0521384 -0.218789 -0.0111000
6 -0.0666851 0.0500422 -0.177503 0.0217857
7 -0.0347796 0.0482399 -0.141375 0.0506903
8 -0.0062121 0.0466576 -0.109088 0.0766335
9 0.0197689 0.0452472 -0.0797814 0.100284
10 0.0436845 0.0439754 -0.0528570 0.122108
20 0.221397 0.0355803 0.145115 0.286370
30 0.349540 0.0312437 0.284438 0.408244
40 0.459033 0.0292557 0.400035 0.515829
50 0.561374 0.0291474 0.504555 0.619913
60 0.663715 0.0307532 0.605621 0.727451
70 0.773209 0.0340907 0.710494 0.845760
80 0.901352 0.0395535 0.830116 0.987334
90 1.07906 0.0488712 0.992544 1.1871491 1.10298 0.0502282 1.01420 1.21423
92 1.12896 0.0517234 1.03768 1.24371
93 1.15753 0.0533905 1.06346 1.27616
94 1.18943 0.0552784 1.09219 1.31246
95 1.22582 0.0574616 1.12491 1.35392
96 1.26857 0.0600631 1.16327 1.40270
97 1.32113 0.0633085 1.21034 1.46276
98 1.39100 0.0676909 1.27277 1.54273
99 1.50112 0.0747255 1.37093 1.66903
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
14/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-74
f = 2: Tolerance Distribution
Parameter Estimates
Standard 95.0% Normal CI
Parameter Estimate Error Lower Upper
Mean 0.465283 0.0329958 0.400612 0.529953
StDev 0.403956 0.0282589 0.352198 0.463319
Table of Percentiles
Standard 95.0% Fiducial CI
Percent Percentile Error Lower Upper
1 -0.474459 0.0766704 -0.646325 -0.340552
2 -0.364341 0.0697856 -0.520318 -0.242102
3 -0.294474 0.0655120 -0.440558 -0.179453
4 -0.241917 0.0623566 -0.380675 -0.132207
5 -0.199165 0.0598338 -0.332051 -0.0936894
6 -0.162777 0.0577218 -0.290734 -0.0608351
7 -0.130871 0.0558997 -0.254566 -0.0319695
8 -0.102304 0.0542942 -0.222234 -0.0060724
9 -0.0763229 0.0528573 -0.192875 0.0175260
10 -0.0524073 0.0515559 -0.165892 0.0392905
20 0.125305 0.0427040 0.0329891 0.202644
30 0.253448 0.0376004 0.173847 0.322983
40 0.362942 0.0345099 0.291660 0.428352
50 0.465283 0.0329958 0.399014 0.529602
60 0.567624 0.0330004 0.503306 0.633914
70 0.677117 0.0346823 0.611508 0.748895
80 0.805260 0.0385371 0.734347 0.887252
90 0.982973 0.0462875 0.899894 1.0839491 1.00689 0.0474826 0.921870 1.11071
92 1.03287 0.0488128 0.945680 1.13986
93 1.06144 0.0503107 0.971790 1.17198
94 1.09334 0.0520233 1.00087 1.20793
95 1.12973 0.0540229 1.03395 1.24902
96 1.17248 0.0564284 1.07270 1.29741
97 1.22504 0.0594584 1.12019 1.35705
98 1.29491 0.0635920 1.18312 1.43653
99 1.40502 0.0703037 1.28191 1.56220
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
15/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-75
f = 3: Tolerance Distribution
Parameter Estimates
Standard 95.0% Normal CI
Parameter Estimate Error Lower Upper
Mean 0.0123990 0.0356207 -0.0574164 0.0822144
StDev 0.403956 0.0282589 0.352198 0.463319
Table of Percentiles
Standard 95.0% Fiducial CI
Percent Percentile Error Lower Upper
1 -0.927342 0.0819421 -1.11109 -0.784282
2 -0.817224 0.0750288 -0.985032 -0.685889
3 -0.747358 0.0707272 -0.905217 -0.623295
4 -0.694800 0.0675438 -0.845278 -0.576104
5 -0.652049 0.0649928 -0.796599 -0.537642
6 -0.615660 0.0628521 -0.755225 -0.504845
7 -0.583755 0.0610006 -0.718999 -0.476037
8 -0.555188 0.0593651 -0.686607 -0.450199
9 -0.529206 0.0578974 -0.657187 -0.426662
10 -0.505291 0.0565644 -0.630141 -0.404960
20 -0.327579 0.0473402 -0.430521 -0.242346
30 -0.199436 0.0417348 -0.288661 -0.123009
40 -0.0899420 0.0379801 -0.169516 -0.0189715
50 0.0123990 0.0356207 -0.0604621 0.0805777
60 0.114740 0.0346077 0.0458819 0.182837
70 0.224234 0.0351438 0.156392 0.295510
80 0.352377 0.0377872 0.281665 0.431433
90 0.530089 0.0442858 0.449713 0.62562091 0.554004 0.0453498 0.471950 0.652131
92 0.579986 0.0465463 0.496026 0.681012
93 0.608553 0.0479071 0.522408 0.712859
94 0.640458 0.0494781 0.551772 0.748529
95 0.676847 0.0513295 0.585143 0.789329
96 0.719598 0.0535776 0.624204 0.837409
97 0.772156 0.0564359 0.672038 0.896705
98 0.842022 0.0603728 0.735353 0.975800
99 0.952140 0.0668332 0.834640 1.10097
8/3/2019 6-Statistical Methods in Bioefficicacy Trials
16/16
Some Statistical Techniques for Bio-Efficacy Trials
VI-76
f = 4: Tolerance Distribution
Parameter Estimates
Standard 95.0% Normal CI
Parameter Estimate Error Lower Upper
Mean 1.03893 0.0281126 0.983832 1.09403
StDev 0.403956 0.0282589 0.352198 0.463319
Table of Percentiles
Standard 95.0% Fiducial CI
Percent Percentile Error Lower Upper
1 0.0991908 0.0704720 -0.0590689 0.222048
2 0.209309 0.0634814 0.0671458 0.320289
3 0.279175 0.0591380 0.147044 0.382800
4 0.331733 0.0559298 0.207031 0.429942
5 0.374484 0.0533648 0.255738 0.468376
6 0.410873 0.0512180 0.297124 0.501162
7 0.442778 0.0493668 0.333349 0.529970
8 0.471345 0.0477370 0.365730 0.555819
9 0.497327 0.0462798 0.395129 0.579377
10 0.521242 0.0449617 0.422145 0.601109
20 0.698954 0.0361002 0.621045 0.764443
30 0.827097 0.0312579 0.761380 0.885305
40 0.936591 0.0287349 0.878053 0.991814
50 1.03893 0.0281126 0.983610 1.09486
60 1.14127 0.0292822 1.08555 1.20152
70 1.25077 0.0322921 1.19109 1.31917
80 1.37891 0.0375327 1.31115 1.4603090 1.55662 0.0467137 1.47385 1.65984
91 1.58054 0.0480609 1.49552 1.68691
92 1.60652 0.0495471 1.51903 1.71637
93 1.63509 0.0512059 1.54482 1.74881
94 1.66699 0.0530861 1.57357 1.78509
95 1.70338 0.0552625 1.60629 1.82653
96 1.74613 0.0578580 1.64467 1.87530
97 1.79869 0.0610984 1.69175 1.93535
98 1.86856 0.0654773 1.75419 2.01532
99 1.97867 0.0725110 1.85234 2.14162
Interpretation: The goodness-of-fit tests (p-values = 0.909) suggest that the distributionand model fits the data adequately. The test for equal slopes is not significant (p-value =
0.673). The log ED50 for the four analgesics are 0.561374, 0.465283, 0.0123990 and
1.03893. ED50 values are 3.642286, 2.919329, 1.028961, 10.9378 . The relative potenciescan easily be worked out.